The Mast Cell in Inflammatory Arthritis
- 24 April 2003
- journal article
- review article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 348 (17) , 1709-1711
- https://doi.org/10.1056/nejmcibr023206
Abstract
Rheumatoid arthritis is a chronic destructive disease of joints, characterized by inflammation, synovial hyperplasia, and abnormal cellular and humoral immune responses. Although several types of cells have been proposed to trigger synovial inflammation, the etiologic process and pathogenesis of the disease remain controversial. But, as indicated by a recent study by Lee et al.,1 the mast cell is emerging as a key player in the erosive and inflammatory events leading to joint destruction (Figure 1).The inflammatory processes that result in rheumatoid arthritis are multifactorial, involving complex interactions among the cytokine network, autoantibodies, and the complement cascade. Various mediators are . . .Keywords
This publication has 5 references indexed in Scilit:
- Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory ArthritisScience, 2002
- Development of anti-TNF therapy for rheumatoid arthritisNature Reviews Immunology, 2002
- The activation of synovial mast cells: modulation of histamine release by tryptase and chymase and their inhibitorsEuropean Journal of Pharmacology, 2001
- Mast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesionArthritis Research & Therapy, 1999
- Mast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.Annals of the Rheumatic Diseases, 1995